Apexium Financial’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$4.02M Sell
21,661
-195
-0.9% -$33.4K 0.2% 60
2025
Q2
$3.34M Sell
21,856
-2,133
-9% -$328K 0.18% 67
2025
Q1
$3.98M Buy
23,989
+2,310
+11% +$361K 0.24% 51
2024
Q4
$3.14M Buy
21,679
+11,262
+108% +$1.75M 0.19% 57
2024
Q3
$1.69M Buy
10,417
+205
+2% +$32.7K 0.11% 71
2024
Q2
$1.49M Buy
10,212
+182
+2% +$27.1K 0.11% 70
2024
Q1
$1.59M Sell
10,030
-4,982
-33% -$793K 0.12% 72
2023
Q4
$2.35M Buy
15,012
+4,503
+43% +$690K 0.17% 64
2023
Q3
$1.64M Sell
10,509
-145
-1% -$23.9K 0.16% 63
2023
Q2
$1.76M Buy
10,654
+273
+3% +$44.1K 0.16% 59
2023
Q1
$1.61M Buy
10,381
+5
+0% +$807 0.16% 65
2022
Q4
$1.83M Buy
10,376
+385
+4% +$66.5K 0.19% 55
2022
Q3
$1.63M Buy
9,991
+7,484
+299% +$1.27M 0.2% 52
2022
Q2
$445K Buy
2,507
+461
+23% +$82.1K 0.26% 60
2022
Q1
$356K Buy
2,046
+40
+2% +$6.81K 0.19% 66
2021
Q4
$343K Buy
2,006
+41
+2% +$6.71K 0.18% 70
2021
Q3
$317K Buy
1,965
+150
+8% +$25.6K 0.18% 68
2021
Q2
$299K Buy
1,815
+500
+38% +$82.8K 0.19% 61
2021
Q1
$216K Sell
1,315
-239
-15% -$38.7K 0.16% 72
2020
Q4
$245K Sell
1,554
-148
-9% -$21.8K 0.19% 62
2020
Q3
$253K Buy
1,702
+65
+4% +$9.62K 0.21% 58
2020
Q2
$230K Hold
1,637
0.21% 56
2020
Q1
$215K Sell
1,637
-685
-30% -$97.2K 0.28% 52
2019
Q4
$339K Buy
+2,322
New +$315K 0.44% 44

Other funds holding JNJ

Apexium Financial's JNJ Position: Q3 2025 in Review

Apexium Financial reduced its Johnson & Johnson (JNJ) stake by 0.89% in Q3 2025, selling an estimated $33.4K and leaving 21,661 shares worth $4.02M. The position accounts for 0.2% of the portfolio, ranked #60.

Apexium Financial first reported a position in JNJ in Q4 2019 and has held it in 24 quarters since. 4,187 funds tracked by Wall St. Rank hold JNJ as of Q3 2025.

  • Apexium Financial held 21,661 shares of Johnson & Johnson worth $4.02M as of Q3 2025.
  • Apexium Financial sold 195 Johnson & Johnson shares in Q3 2025, an estimated $33.4K.
  • Johnson & Johnson made up 0.2% of Apexium Financial's portfolio in Q3 2025, its #60 holding.
  • Apexium Financial first reported a position in Johnson & Johnson in Q4 2019 and has held it in 24 quarters since.
  • 4,187 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2025.

Based on Apexium Financial's 13F filing for Q3 2025, filed 18 Nov 2025.